Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @BioLinkAus
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BioLinkAus
-
Prikvačeni tweet
What a week! Bio-Link was delighted to represent our client,
@ActinogenMed, at#JPM2020. We travelled over 31 km (generally on foot) around San Francisco, meeting with leading pharma executives, sharing the latest exciting data and future strategy for the development of#Xanamempic.twitter.com/FZYOXZ2777
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bridging the gap between science & business. Don’t miss out on the Symposium co-hosted by Bio-Link partner
@CCRM_au and the NSW Stem Cell Network. Come and learn more about accelerating commercialisation of#regenerativemedicine. Register: https://bit.ly/2NbAG9K pic.twitter.com/9EY58eC7mp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Sacred Word: De-risking biotech messaging panel event at
#AusBio19 was a success! If you’d like to learn more about this subject, read the@Ausbiotech article (https://bit.ly/31tdOa9 ) or contact Bio-Link (https://bit.ly/34uysIU ).pic.twitter.com/KZ1M2cdsH0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bio-Link's
@CToouli will be representing@ActinogenMed at@AusBiotech’s annual conference,#AusBio19.pic.twitter.com/i7IqoFppLz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you interested in global business development for your company? Join us at
@AusBiotech’s annual conference,#AusBio19, and meet Bio-Link's Lilly Bojarski, Senior Business Development Associate. Learn more: https://bit.ly/2BSAki2 pic.twitter.com/tDIvQi1sBr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bio-Link is pleased to see the progression of a client's technology, as the basis of a $20M Series A funding of Kira Biotech (https://bit.ly/34bsNqN ). The technology was incubated over the last few years through an earlier deal (https://bit.ly/2MYztTu ) facilitated by Bio-Link.pic.twitter.com/ebXZ0YuXcv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are delighted to welcome Kate Samardzic to the Bio-Link team as a Business Development Associate. Learn more about Kate and the rest of the Bio-Link team: http://bio-link.com/team/ .
#biotechnologypic.twitter.com/LqDoyZQYlB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Take a sneak peek at
@AusBiotech ’s 2019 national conference with@BioLinkAus Executive Director@CToouli ’s article “The Sacred Word: De-risking biotech messaging”. Read it in the new edition of Australasian Biotechnology (pg 36): https://bit.ly/31tdOa9#Biotechnologypic.twitter.com/h2mbghItg9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@US_FDA has launched an initiative in collaboration with@TGAgovau and@GovCanHealth to allow the regulatory review of#cancer products to occur in parallel across different countries - Project Orbis.#Biotechnology Find out more: https://bit.ly/2kmwl8x pic.twitter.com/xvZ3wCoIBU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to
@ActinogenMed for their breakthrough results from the XanaHES (Xanamem in Healthy Elderly Subjects) trial! Results show a significant improvement in cognition in trial participants dosed with Xanamem. ASX Announcement: https://bit.ly/2olzfvM#Alzheimerspic.twitter.com/mgZpTa1ad5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bio-Link is excited to announce our new
#partnership with@CCRM_au!#biotechnologypic.twitter.com/0ktnWU5veH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Over the past year, the
#biopharma industry has witnessed some landmark approvals, high-value merger and acquisition deals and phenomenal venture funding in the US.@bpdealmakers chart the key trends since June 2018: http://ow.ly/9GIC50vSQbR pic.twitter.com/hGHyd6RGHN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
If you needed
#insulin and couldn't afford the $1000/month#drugprices, would you consider brewing your own drug at home? It is possible! Find out more: http://ow.ly/VZX850vSPYP (Image source: http://ow.ly/lF9z50vSPYQ )pic.twitter.com/A2N1AcFtGW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@US_FDA’s Priority Review Voucher is a great way to expedite the approval of a new drug or biologic, with a decision made in 6 months!#businessdevelopment#commercialisation#lifescience#Pharmaceutical#biotechnologyindustry#biotechpic.twitter.com/xqoQWxuSPF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We recently reached 100+ followers! Thank you all for your support over the years! We would like to find out what you would like to see more of. Please leave your feedback in the comments below.
#biotechnology;#biotech;#biotechnologyindustry;#lifesciences;#pharmaceutical;pic.twitter.com/I5Y6gz6fSH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#funding is often a challenge in the#biotechnologyindustry, but Chipscreen had no such issues, with shares for their IPO being 3000Xs oversubscribed on China’s new tech board! How did this happen? Why did it happen? Most importantly, can we make it happen here in#Australia?pic.twitter.com/Z0gYPNCgdq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Recent analysis of the
#biopharma industry as reported by@endpts showed that for most listed large companies, cumulative R&D investment over the past 5 years exceeded sales of new drugs over the same period.#commercialisation#biotech#drugdevelopment Image courtesy@endptspic.twitter.com/l0JOAv568l
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Good news for the
#biotech industry as the “environment is much better than a few years ago”-@fderubertis@medicxi closed a €400M#biopharma fund, establishing an "operational platform" for the "drug hunters and the maverick scientists". Source article http://ow.ly/1EqB50veDqd pic.twitter.com/B2p3y2bGWT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Boston-based
@BainCapVC raised $900M for its second#lifesciences#fund. Closer to home,@brandoncapital raised $210M for the 5th#MRCF. We help investors#scout for#businessopportunities and provide#strategic advisory services to review#science and develop#business cases.pic.twitter.com/JJbvGk6zeb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Several therapeutic candidates testing the amyloid hypothesis in
#Alzheimer’s disease (AD) have recently been evaluated in large multicentre Phase III clinical trials, unfortunately without success. Bio-Link's insight into the matter: https://bit.ly/30mAo41#businessdevelopmentpic.twitter.com/r3KT4oMDrE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.